Nutex Health Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $875.3 | $479.9 | $247.6 | $219.3 | $331.5 |
| Operating income | $275.6 | $130.7 | -$31.8 | -$406.6 | $170.3 |
| Net income | $70.8 | $52.1 | -$45.8 | -$424.8 | $132.6 |
| Balance Sheet | |||||
| Total debt | $43.5 | $41.4 | $42.4 | $38.3 | $89.4 |
| Cash Flow Statement | |||||
| Free cash flow | $245.6 | $20.8 | -$8.2 | $36.0 | $136.5 |
| Share repurchases | $5.0 | $0.0 | $0.0 | — | — |
Shares outstanding 6.9M
Annual filing data through FY ended December 31, 2025; float as of August 30, 2026.